Andrew Haydon
- Oncology top 1%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Physiology top 10%
- Co-authors
- Graham G. GilesDallas R. EnglishRobert J. MacInnisJohn L. HopperDorota M. GertigStuart K. RobertsHelen KavnoudiasChristine Ball
- Topics
- Cancer Immunotherapy and Biomarkers (40 papers)Melanoma and MAPK Pathways (32 papers)Cutaneous Melanoma Detection and Management (32 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Andrew Haydon
135 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.9k
- Molecular Biology 751
- Pulmonary and Respiratory Medicine 464
- Immunology 398
- Physiology 351
Countries citing papers authored by Andrew Haydon
This map shows the geographic impact of Andrew Haydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Haydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Haydon more than expected).
Fields of papers citing papers by Andrew Haydon
This network shows the impact of papers produced by Andrew Haydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Haydon. The network helps show where Andrew Haydon may publish in the future.
Co-authorship network of co-authors of Andrew Haydon
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Haydon. A scholar is included among the top collaborators of Andrew Haydon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Haydon. Andrew Haydon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 30 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 14 | |
| 9 | 23 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 12 | |
| 14 | 4 | |
| 15 | 3 | |
| 16 | 2 | |
| 17 | 18 | |
| 18 | 122 | |
| 19 | 37 | |
| 20 | 76 |
About Andrew Haydon
Andrew Haydon is a scholar working on Oncology, Immunology and Research and Theory, having authored 143 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (40 papers), Melanoma and MAPK Pathways (32 papers) and Cutaneous Melanoma Detection and Management (32 papers). The work is most often cited by research in Oncology (1.9k citations), Biotechnology (288 citations) and Pathology and Forensic Medicine (345 citations). Andrew Haydon has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Graham G. Giles, Dallas R. English, Robert J. MacInnis, John L. Hopper, Dorota M. Gertig, Stuart K. Roberts, Helen Kavnoudias, Christine Ball, Peter Evans and Kenneth R. Thomson. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.